NICE, France & ARVADA, Colo.--(BUSINESS WIRE)--June 15, 2006--ELA Medical, part of Sorin Group (MIL:SRN), announced the first U.S. implants of its OVATIO(TM) implantable cardioverter defibrillator (ICD) family, which recently received U.S. Food and Drug Administration (FDA) clearance. These implants were conducted by Doctors Atul Prakash, Rodrigo Chan, and Louis Rechani on May 22, in New Jersey, Arizona, and Florida respectively. At 29cc, OVATIO is the world's smallest ICD. In addition, OVATIO dual-chamber model (DR) contains multiple unique features including; AAIsafeR mode, which prevents unnecessary right ventricular pacing, and PARAD+ ®, the second-generation of PARAD which is an industry-best algorithm for minimizing inappropriate shocks.
